BioSpace News Archive

Policy

BMS Follows Merck’s Lead, Sues Government Over Drug Pricing Negotiation

On the heels of a legal challenge to the Inflation Reduction Act by Merck, Bristol Myers Squibb on Friday filed its own lawsuit claiming that the law’s drug price negotiation provision is unconstitutional.

June 19, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Lilly’s Migraine Drug Emgality Fails to Outperform Pfizer’s Nurtec

In the first head-to-head trial of CGRP antagonists, Lilly’s Emgality failed to demonstrate that it was significantly better than Pfizer’s Nurtec ODT at easing migraine headaches.

June 19, 2023
·
2 min read
·
Tristan Manalac
Drug Development

BioSenic Puts Fracture Cell Therapy Program on Hold After Mid-Stage Failure

Following disappointing Phase IIb results, BioSenic is pausing the development of its tibial fracture cell therapy ALLOB derived from mesenchymal stem cells.

June 19, 2023
·
2 min read
·
Tristan Manalac
Yourgene Health Presents Data Demonstrating Successful Fetal Fraction Enrichment in NIPT Workflows Following Prolonged Blood Storage in EDTA Tubes

Yourgene Health plc, a leading international molecular diagnostics group, presented data demonstrating that prolonged storage of blood in EDTA tubes is compatible with non-invasive prenatal testing when using size selection to enrich the fetal fraction.

June 19, 2023
·
3 min read
Pharm Country

MTTI Announces Favorable Three-Year Follow-Up for EBTATE in Neuroendocrine Tumors

Molecular Targeting Technologies, Inc. announced favorable findings of a 3-year follow-up of EBTATE against metastatic gastroenteropancreatic neuroendocrine tumors.

June 19, 2023
·
2 min read
Business

American Psychedelic Practitioners Association Announces Appointment of Brigadier General (Ret.) Stephen N. Xenakis, MD as new Executive Director

American Psychedelic Practitioners Association (APPA) has announced the appointment of Brigadier General (Ret.) Stephen N. Xenakis, MD as new Executive Director of the organization.

June 19, 2023
·
3 min read
Business

NLS Pharmaceutics Announces Company Update Webcast

NLS Pharmaceutics Ltd. today announced plans to showcase its global strategic R&D progress and platform.

June 19, 2023
·
1 min read
Cleantech Blue-Zone Technologies Signs Letter of Intent with Leading Medical Gas Equipment Manufacturer, Class 1Parties consider collaborative agreement for the collection and conversion of anesthetic gases

Blue-Zone Technologies Ltd. announced it has signed a letter of intent with Canada’s leading medical gas equipment manufacturer, distributor and service provider, Class 1 Incorporated.

June 19, 2023
·
3 min read
Salix to Present Data from XIFAXAN(R) (Rifaximin) Clinical Research at EASL’s International Liver Congress(TM) 2023

Bausch Health Companies Inc. , today announced its presence at the European Association for the Study of the Liver (EASL) Congress 2023.

June 19, 2023
·
4 min read
invIOs presents exciting preclinical data showing that immune-activating small molecule INV501 induces strong cytotoxic activity against solid tumors

invIOs GmbH today publicly disclosed data for the first time from its high-potential small molecule program, INV501, showing that the novel compound can induce strong anti-tumor immune responses.

June 19, 2023
·
3 min read